EconPapers    
Economics at your fingertips  
 

Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs

Vincent L. Chen (), Don C. Rockey (), Einar S. Bjornsson (), Huiman Barnhart () and Jay H. Hoofnagle ()
Additional contact information
Vincent L. Chen: University of Michigan School of Medicine
Don C. Rockey: Medical University of South Carolina
Einar S. Bjornsson: Landspitali University Hospital
Huiman Barnhart: Duke University
Jay H. Hoofnagle: National Institutes of Health

Drug Safety, 2025, vol. 48, issue 2, No 5, 160 pages

Abstract: Abstract Background The incidence of drug-induced liver injury (DILI) is not known for most prescription medications. We aimed to estimate the incidence of DILI for commonly prescribed outpatient drugs. Methods To establish a baseline estimate of DILI incidence, we used the estimated incidence (EI) of amoxicillin/clavulanate DILI from a previous population-based study in Iceland. This was combined with the multicenter prospective DILI Network (DILIN) cohort and the US population-based Medical Expenditure Panel Survey (MEPS). From 2005 to 2019, prescription drugs with at least five bona fide DILIN cases and data from at least 10 of the 15 years from MEPS during that timeframe were included. The EI for ‘drug A’ was calculated as follows: $$\text{EI}(\text{drug A})=\text{EI}\left(\text{AC}\right)\times \frac{\# \; \text{DILIN cases of drug A}}{\# \; \text{annual new prescriptions of drug A}}\times \frac{\# \; \text{annual new prescriptions of AC}}{\# \; \text{DILIN cases of AC}}$$ EI ( drug A ) = EI AC × # DILIN cases of drug A # annual new prescriptions of drug A × # annual new prescriptions of AC # DILIN cases of AC Results In total, 30 drugs met the inclusion criteria, of which 11 were antibiotics, 4 were antiepileptic drugs (AEDs), 4 were statins, and 11 were other drug types. The highest EI was seen with azathioprine and older AEDs, with one DILI case per 349–2329 new prescriptions. The EI of antibiotics ranged greatly, with the highest risk seen for minocycline, amoxicillin/clavulanate, and nitrofurantoin (approximately 1:1000–2400 new prescriptions), and lowest risk for clindamycin, doxycycline, azithromycin, and amoxicillin (approximately 1:40,000–170,000 new prescriptions). The EI for commonly prescribed statins was approximately 1:10,000–50,000. Important medication classes with > 5 million new prescriptions from 2005 to 2019 but fewer than five DILIN cases included β-blockers, thiazide diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, selective serotonin reuptake inhibitors, and metformin, which presumably have very low DILI incidence. Conclusions The highest EI was found for azathioprine, older antiepileptics, and minocycline. In contrast, many widely used drugs are rare causes of DILI. These findings may help clinicians better weigh potential benefits of medications against hepatotoxicity risk.

Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-024-01486-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:48:y:2025:i:2:d:10.1007_s40264-024-01486-6

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-024-01486-6

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-12
Handle: RePEc:spr:drugsa:v:48:y:2025:i:2:d:10.1007_s40264-024-01486-6